Generation Bio Co. announced terminate the employment of Douglas Kerr, M.D., Ph.D., M.B.A., the Company?s Chief Medical Officer, and Tracy Zimmermann, Ph.D., the Company?s Chief Development Officer, effective as of January 28, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | -6.44% | -3.94% | +84.55% |
May. 09 | Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting | CI |
Apr. 12 | Transcript : Generation Bio Co. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+84.55% | 217M | |
+2.61% | 108B | |
+11.05% | 104B | |
+1.51% | 22.33B | |
-11.90% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.12% | 17.64B | |
+5.30% | 14.05B | |
+34.89% | 12.51B |
- Stock Market
- Equities
- GBIO Stock
- News Generation Bio Co.
- Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024